DOD Multiple Sclerosis Exploration - Hypothesis Development Award | W81XWH 21 MSRP EHDA

Opportunity Information: Apply for W81XWH 21 MSRP EHDA

The DOD Multiple Sclerosis Exploration - Hypothesis Development Award (Funding Opportunity Number W81XWH 21 MSRP EHDA) is a Department of Defense research funding opportunity run through the Department of the Army, U.S. Army Medical Research Acquisition Activity (USAMRAA). It is designed to fund early-stage multiple sclerosis (MS) research ideas that are intentionally bold and exploratory, especially projects that might be considered too risky or too novel for more traditional funding mechanisms but could pay off in a big way if successful. The core intent is to support work that can open up entirely new directions in MS science and set the stage for larger follow-on studies and future funding.

This award specifically targets innovative, high-risk, high-gain, and potentially groundbreaking concepts. In practice, that means the project should not simply extend an existing line of research by a small step, and it should not look like a straightforward continuation of what has already been published. The proposal is expected to introduce something genuinely new to the MS field, such as a novel paradigm for understanding disease mechanisms, a creative approach to treatment or prevention, a challenge to widely held assumptions, or a fresh way to interpret an established problem. A key requirement is that the Principal Investigator clearly explains what makes the project innovative and why it is meaningfully different from incremental advances.

Even though the program supports exploratory research, it is not meant to be vague or purely speculative. Applicants are expected to put forward a well-formulated and testable hypothesis, backed by a strong scientific rationale and an appropriate study design. One notable feature of this mechanism is that preliminary data and/or published supporting data are not required, which lowers the barrier for proposing genuinely new ideas that have not yet generated proof-of-concept results. That said, the hypothesis and approach still need to be coherent, logically grounded, and structured in a way that can realistically produce interpretable outcomes.

From an administrative and funding perspective, the opportunity falls under the Science and Technology and other Research and Development category (CFDA 12.420) and can be awarded as either a grant or a cooperative agreement. Eligibility is listed as unrestricted, meaning it is open to any type of applicant entity, subject to any additional eligibility clarifications that might appear in the full announcement. The opportunity was created on May 10, 2021, with an original closing date of October 1, 2021. The listing anticipates making about eight awards. The award ceiling is shown as 0 in the source data, which typically indicates the cap is not specified in that field and applicants should rely on the full funding announcement for any budget limits, cost constraints, or recommended funding levels.

Overall, this program is best suited for investigators who have a strong, testable idea that could meaningfully shift how MS is studied or addressed, but who may not yet have the preliminary dataset that other mechanisms demand. The review emphasis is likely to center on the clarity and testability of the hypothesis, the strength of the scientific rationale, the appropriateness of the design for an exploratory effort, and most importantly, a convincing case that the work is truly innovative rather than a modest extension of existing research.

• The Department of Defense, Dept. of the Army -- USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DOD Multiple Sclerosis Exploration - Hypothesis Development Award" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
• This funding opportunity was created on May 10, 2021.
• Applicants must submit their applications by Oct 01, 2021. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 8 candidate(s).
• Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.

Apply for W81XWH 21 MSRP EHDA

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: